We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Intuitive Surgical, Inc. (ISRG) Dips More Than Broader Market: What You Should Know
Read MoreHide Full Article
In the latest close session, Intuitive Surgical, Inc. (ISRG - Free Report) was down 1.09% at $566.36. This change lagged the S&P 500's daily loss of 0.74%. Elsewhere, the Dow saw a downswing of 0.63%, while the tech-heavy Nasdaq depreciated by 0.76%.
Heading into today, shares of the company had gained 0.86% over the past month, outpacing the Medical sector's loss of 0.8% and the S&P 500's gain of 0.79%.
Investors will be eagerly watching for the performance of Intuitive Surgical, Inc. in its upcoming earnings disclosure. On that day, Intuitive Surgical, Inc. is projected to report earnings of $2.25 per share, which would represent year-over-year growth of 1.81%. At the same time, our most recent consensus estimate is projecting a revenue of $2.72 billion, reflecting a 12.59% rise from the equivalent quarter last year.
For the entire fiscal year, the Zacks Consensus Estimates are projecting earnings of $8.65 per share and a revenue of $9.92 billion, representing changes of +17.85% and +18.72%, respectively, from the prior year.
Investors should also take note of any recent adjustments to analyst estimates for Intuitive Surgical, Inc. Such recent modifications usually signify the changing landscape of near-term business trends. Consequently, upward revisions in estimates express analysts' positivity towards the business operations and its ability to generate profits.
Based on our research, we believe these estimate revisions are directly related to near-term stock moves. To utilize this, we have created the Zacks Rank, a proprietary model that integrates these estimate changes and provides a functional rating system.
The Zacks Rank system, stretching from #1 (Strong Buy) to #5 (Strong Sell), has a noteworthy track record of outperforming, validated by third-party audits, with stocks rated #1 producing an average annual return of +25% since the year 1988. Over the last 30 days, the Zacks Consensus EPS estimate has witnessed a 0.58% increase. Intuitive Surgical, Inc. presently features a Zacks Rank of #2 (Buy).
Valuation is also important, so investors should note that Intuitive Surgical, Inc. has a Forward P/E ratio of 66.19 right now. This signifies a premium in comparison to the average Forward P/E of 25.28 for its industry.
Also, we should mention that ISRG has a PEG ratio of 4.22. This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected earnings growth rate. By the end of yesterday's trading, the Medical - Instruments industry had an average PEG ratio of 2.28.
The Medical - Instruments industry is part of the Medical sector. This industry currently has a Zacks Industry Rank of 162, which puts it in the bottom 35% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Don't forget to use Zacks.com to keep track of all these stock-moving metrics, and others, in the upcoming trading sessions.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Intuitive Surgical, Inc. (ISRG) Dips More Than Broader Market: What You Should Know
In the latest close session, Intuitive Surgical, Inc. (ISRG - Free Report) was down 1.09% at $566.36. This change lagged the S&P 500's daily loss of 0.74%. Elsewhere, the Dow saw a downswing of 0.63%, while the tech-heavy Nasdaq depreciated by 0.76%.
Heading into today, shares of the company had gained 0.86% over the past month, outpacing the Medical sector's loss of 0.8% and the S&P 500's gain of 0.79%.
Investors will be eagerly watching for the performance of Intuitive Surgical, Inc. in its upcoming earnings disclosure. On that day, Intuitive Surgical, Inc. is projected to report earnings of $2.25 per share, which would represent year-over-year growth of 1.81%. At the same time, our most recent consensus estimate is projecting a revenue of $2.72 billion, reflecting a 12.59% rise from the equivalent quarter last year.
For the entire fiscal year, the Zacks Consensus Estimates are projecting earnings of $8.65 per share and a revenue of $9.92 billion, representing changes of +17.85% and +18.72%, respectively, from the prior year.
Investors should also take note of any recent adjustments to analyst estimates for Intuitive Surgical, Inc. Such recent modifications usually signify the changing landscape of near-term business trends. Consequently, upward revisions in estimates express analysts' positivity towards the business operations and its ability to generate profits.
Based on our research, we believe these estimate revisions are directly related to near-term stock moves. To utilize this, we have created the Zacks Rank, a proprietary model that integrates these estimate changes and provides a functional rating system.
The Zacks Rank system, stretching from #1 (Strong Buy) to #5 (Strong Sell), has a noteworthy track record of outperforming, validated by third-party audits, with stocks rated #1 producing an average annual return of +25% since the year 1988. Over the last 30 days, the Zacks Consensus EPS estimate has witnessed a 0.58% increase. Intuitive Surgical, Inc. presently features a Zacks Rank of #2 (Buy).
Valuation is also important, so investors should note that Intuitive Surgical, Inc. has a Forward P/E ratio of 66.19 right now. This signifies a premium in comparison to the average Forward P/E of 25.28 for its industry.
Also, we should mention that ISRG has a PEG ratio of 4.22. This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected earnings growth rate. By the end of yesterday's trading, the Medical - Instruments industry had an average PEG ratio of 2.28.
The Medical - Instruments industry is part of the Medical sector. This industry currently has a Zacks Industry Rank of 162, which puts it in the bottom 35% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Don't forget to use Zacks.com to keep track of all these stock-moving metrics, and others, in the upcoming trading sessions.